Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 17, 2016 - Issue 8
Submit an article Journal homepage
886
Views
12
CrossRef citations to date
0
Altmetric
Review

Chronic lymphocytic leukemia therapy: new targeted therapies on the way

Candida VitaleDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
&
Jan A. BurgerDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
Pages 1077-1089 | Received 27 Jan 2016, Accepted 10 Mar 2016, Published online: 12 Apr 2016

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Wilma Barcellini, Juri Giannotta & Bruno Fattizzo. (2020) Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures. Expert Review of Hematology 13:6, pages 585-597.
Read now

Articles from other publishers (11)

Mazyar Shadman, Beenish S. Manzoor, Kavita Sail, Hande H. Tuncer, John N. Allan, Chaitra Ujjani, Nnadozie Emechebe, Rajesh Kamalakar, Catherine C. Coombs, Lori Leslie, Paul M. Barr, Jennifer R. Brown, Toby A. Eyre, Alexandros Rampotas, Anna Schuh, Nicole Lamanna, Alan Skarbnik, Lindsey E. Roeker, Rajat Bannerji, Barbara Eichhorst, Isabelle Fleury, Matthew S. Davids, Hasan Alhasani, Dingfeng Jiang, Brian T. Hill, Stephen J. Schuster, Danielle M. Brander, Irina Pivneva, Rebecca Burne, Annie Guerin & Anthony R. Mato. (2023) Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study. Clinical Lymphoma Myeloma and Leukemia 23:7, pages 515-526.
Crossref
Richard R. Furman, John C. Byrd, Roger G. Owen, Susan M. O’Brien, Jennifer R. Brown, Peter Hillmen, Deborah M. Stephens, Nataliya Chernyukhin, Tamara Lezhava, Ahmed M. Hamdy, Raquel Izumi, Priti Patel, Marshall Baek, Beth Christian, Martin J. S. Dyer, Matthew J. Streetly, Clare Sun, Simon Rule, Michael Wang, Paolo Ghia, Wojciech Jurczak, John M. Pagel & Jeff P. Sharman. (2021) Pooled analysis of safety data from clinical trials evaluating acalabrutinib monotherapy in mature B-cell malignancies. Leukemia 35:11, pages 3201-3211.
Crossref
Jennifer R. Brown, John C. Byrd, Paolo Ghia, Jeff P. Sharman, Peter Hillmen, Deborah M. Stephens, Clare Sun, Wojciech Jurczak, John M. Pagel, Alessandra Ferrajoli, Priti Patel, Lin Tao, Nataliya Kuptsova-Clarkson, Javid Moslehi & Richard R. Furman. (2021) Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients. Haematologica 107:6, pages 1335-1346.
Crossref
Sunil K. Noothi, Mary K. McKenna, Sara S. Alhakeem, James P. Collard, J. T. Greene, Natarajan Muthusamy, Vivek M. Rangnekar & Subbarao Bondada. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4 133 148 .
Ayad M. Al‐Katib, Hussein Gaith, Dahlia Sano, Sayf Al‐Katib, Michelle Bonnett & Zyad Kafri. (2020) Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy. Clinical Case Reports 8:9, pages 1797-1801.
Crossref
Sigrid S. Skånland, Andrea Cremaschi, Henrik Bendiksen, Johanne U. Hermansen, Deepak B. Thimiri Govinda Raj, Ludvig A. Munthe, Geir E. Tjønnfjord & Kjetil Taskén. (2019) An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL. Leukemia 34:2, pages 478-487.
Crossref
Paolo Giannoni, Franco Fais, Giovanna Cutrona & Daniela Totero. (2019) Hepatocyte Growth Factor: A Microenvironmental Resource for Leukemic Cell Growth. International Journal of Molecular Sciences 20:2, pages 292.
Crossref
Marius E. Mayerhoefer, Ulrich Jaeger, Philipp Staber, Markus Raderer, Wolfgang Wadsak, Sarah Pfaff, Christoph Kornauth, Daniela Senn, Michael Weber, Hans-Juergen Wester, Cathrin Skrabs & Alexander Haug. (2018) [68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia. Investigative Radiology 53:7, pages 403-408.
Crossref
Chiara CavalliniRoberto Chignola, Ilaria DandoOmar Perbellini, Elda MimiolaOrnella LovatoCarlo Laudanna, Giovanni PizzoloMassimo DonadelliMaria Teresa Scupoli. (2018) Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL. Blood 131:17, pages 1942-1954.
Crossref
Julia C. GutjahrEva SzenesLisa TschechDaniela AsslaberMichaela SchledererSimone RoosXiaobing YuTamara GirblChristina Sternberg, Alexander EgleFritz Aberger, Ronen Alon, Lukas KennerRichard GreilVeronique Orian-RousseauTanja N. Hartmann. (2018) Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia. Blood 131:12, pages 1337-1349.
Crossref
Narendra Agarwal, Rayaz Ahmed & Dinesh Bhurani. (2019) Blood cancers: Flowing the right way!. Asian Journal of Oncology 02:01, pages 001-002.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.